Literature DB >> 22416290

Abstracts of the 43rd Annual Meeting of the Society of Gynecologic Oncology. March 24-27, 2012. Austin, Texas, USA.

.   

Abstract

Mesh：

Year:  2012        PMID： 22416290

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  2 in total

1.  A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.

Authors:  Matthew A Powell; Michael W Sill; Paul J Goodfellow; Doris M Benbrook; Heather A Lankes; Kimberly K Leslie; Yvette Jeske; Robert S Mannel; Monique A Spillman; Paula S Lee; James S Hoffman; D Scott McMeekin; Pamela M Pollock
Journal:  Gynecol Oncol       Date:  2014-07-11       Impact factor: 5.482

2.  An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021).

Authors:  Shin-Wha Lee; Yong-Man Kim; Chi Heum Cho; Young Tae Kim; Seok Mo Kim; Soo Young Hur; Jae-Hoon Kim; Byoung-Gie Kim; Seung-Cheol Kim; Hee-Sug Ryu; Soon Beom Kang
Journal:  Cancer Res Treat       Date:  2017-03-21       Impact factor: 4.679
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.